Allergan Eases Manual Data Entry and Contract Management Pains with Pramata’s Billing Accuracy Solution
June 28 2018 - 8:00AM
Pramata, the leading commercial relationship operations company,
today announced that global pharmaceutical leader Allergan has
implemented the Pramata Billing Accuracy solution. Allergan, which
recorded $16 billion in revenues in 2017, cited rapid growth and
complexity of commercial relationships as catalysts for seeking an
automated solution to enhance contract management capabilities and
revenue control.
“Since we've gone live with Pramata, we've generated a lot of
excitement and adoption around the solution, and our team is seeing
huge strides in our contract reporting capabilities,” said Michael
Richardson, Executive Director, Allergan. “Pramata enables us to
retrieve specific information within customer contracts in minutes
or a few hours, compared to the many hours it took before
implementation.”
By using Pramata, Allergan sees significant value in
dramatically improved information accuracy, better managed customer
pricing variables, and better assurance of account alignment.
“To me, the most attractive thing about Pramata is the
software-as-a-service aspect. It allows us to basically eliminate
the need to manually enter this information,” said Richardson.
“With Pramata, we have a team that is digitizing our documents,
understanding the nature of the terms and conditions, normalizing
the data, and then updating the software platform according to our
design specifications. To me, that is a huge benefit.”
With Pramata, Allergan takes a complex and diverse array of
commercial agreements, efficiently captures the important terms of
those agreements and delivers this information in the most useful
and actionable way to stakeholders who manage the company’s
contract commitments and requirements. Pramata handles the heavy
lifting, allowing Allergan to see a measurable difference in
resource commitment and related costs.
“Our Billing Accuracy solution targets a key point in the
customer lifecycle where companies are often spinning their wheels
trying to piece together critical commercial terms and coming up
way short on accuracy and their ability to avoid revenue leakage,”
said Praful Saklani, CEO at Pramata. “It’s exciting to see Allergan
using Pramata to bring their relationships into a clearer, more
actionable view for their finance teams and to witness
results.”
“A key element to what Pramata offers is a team that is
dedicated to Allergan,” said Lauren Dwyer Mihlon, Associate
Director, Strategic Contracting, Allergan. “They know our business
inside and out. So, the communication between us that keeps our
commercial relationship system of record up to date works very
well. There are other systems available, but Pramata’s power and
capabilities are tailored to the enhancements we were seeking.”
About Allergan PLC
Allergan plc (NYSE:AGN), headquartered in Dublin,
Ireland, is a bold, global pharmaceutical leader. Allergan is
focused on developing, manufacturing and commercializing branded
pharmaceutical, device, biologic, surgical and regenerative
medicine products for patients around the world.
About PramataPramata helps large B2B
enterprises eliminate revenue leakage. Pramata has created millions
of dollars in value for some of the largest companies in the world
including Allergan, CenturyLink, Comcast Business, FICO, NCR, Micro
Focus, Novelis and Vertafore. Headquartered in Brisbane, CA,
Pramata also has offices in Kansas City, MO, and Bangalore, India.
For more information, visit www.pramata.com.
Media Contact:
Marina GreenwoodActiva PR for
Pramata415.776.5350marina@activapr.com
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2024 to May 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From May 2023 to May 2024